Optomed USA Launches Disposable Eye Cup

Available for Optomed Handheld Fundus Cameras

Optomed E-Safe

Optomed USA, Inc., a wholly owned subsidiary of Optomed Plc, introduces Optomed E-Safe, a disposable eye cup, to be used with its handheld fundus cameras. "The current pandemic situation accelerated the need to offer convenient solutions such as our disposable eye cup to deliver safe and hygienic eye exams without the need for a disinfection protocol," said Jean-Christophe Firer, President & CEO of Optomed USA, Inc.  

The Optomed E-Safe eye cup is made from thermoplastic polyurethane disposable material. The eye cup is attached to the camera's eyepiece, which rests against the patient during imaging. The single patient use product makes it easy for the eye care professional to safely image patients. The Optomed E-Safe disposable eye cup is available at www.optomed.com/us/buy-now or by contacting your Optomed representative.


Jean-Christophe Firer, President & CEO, Optomed USA, Inc, jc.firer@optomed.com (844) 474-4481

About Optomed

Optomed Plc is a Finnish medical technology company and one of the leading providers of handheld fundus cameras worldwide. Optomed Plc combines handheld screening devices with software and optional artificial intelligence integration with the aim to transform the diagnostic process of blinding eye diseases such as rapidly increasing diabetic retinopathy. In its business, Optomed Plc focuses on eye-screening devices and software solutions-related R&D in Finland and sales through different channels in over 60 countries. Optomed Plc has an extensive portfolio of over 50 international patents protecting the technology.

Forward-Looking Statements

This press release contains " forward-looking statements"  relating to future events. These statements may be identified by words such as " may," "could," "expects," "intends," "anticipates," "plans," "believes," "aims," "estimates," or words of similar meaning. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performance or achievements of Optomed Plc and its affiliates (including Optomed USA, Inc.) may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which are beyond the control of Optomed USA, Inc. and its affiliates, including, without limitation, the global spread of COVID-19, or the Coronavirus, and the various restrictions deriving therefrom. In addition, Optomed Plc and its affiliates (including Optomed USA, Inc.) rely, and expect to continue to rely, on third parties to conduct certain activities, and if these third parties do not successfully carry out their contractual duties, comply with regulatory requirements or meet expected deadlines (including as a result of the effect of the Coronavirus), Optomed Plc and its affiliates (including Optomed USA, Inc.) may experience significant delays in the conduct of their activities. Optomed Plc and its affiliates (including Optomed USA, Inc.) disclaim any obligation or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations, estimates, projections and assumptions.

Source: Optomed USA, Inc.

About Optomed USA Inc.

Optomed USA, Inc., a wholly owned subsidiary of Optomed Plc, a Finnish medical technology company.

Optomed USA Inc.
1153 Wenig Court
Pleasanton, CA

More Press Releases